My NCBI | Sign In
RSS Settings
  • Search: Flavell DM[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 25

    1.

    IP receptor-dependent activation of PPARgamma by stable prostacyclin analogues.

    Falcetti E, Flavell DM, Staels B, Tinker A, Haworth SG, Clapp LH.

    Biochem Biophys Res Commun. 2007 Sep 7;360(4):821-7. Epub 2007 Jul 5.PMID: 17624303 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.

    Talmud PJ, Flavell DM, Alfakih K, Cooper JA, Balmforth AJ, Sivananthan M, Montgomery HE, Hall AS, Humphries SE.

    Clin Sci (Lond). 2007 Jun;112(12):617-24.PMID: 17291198 [PubMed - indexed for MEDLINE]Related articles

    3.

    Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training.

    Wootton PT, Flavell DM, Montgomery HE, World M, Humphries SE, Talmud PJ.

    Nutr Metab Cardiovasc Dis. 2007 Jan;17(1):24-31. Epub 2006 Mar 20.PMID: 17174223 [PubMed - indexed for MEDLINE]Related articles

    4.

    PPARalpha gene variation and physical performance in Russian athletes.

    Ahmetov II, Mozhayskaya IA, Flavell DM, Astratenkova IV, Komkova AI, Lyubaeva EV, Tarakin PP, Shenkman BS, Vdovina AB, Netreba AI, Popov DV, Vinogradova OL, Montgomery HE, Rogozkin VA.

    Eur J Appl Physiol. 2006 May;97(1):103-8. Epub 2006 Feb 28.PMID: 16506057 [PubMed - indexed for MEDLINE]Related articles

    5.

    Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth.

    Flavell DM, Wootton PT, Myerson SG, World MJ, Pennell DJ, Humphries SE, Talmud PJ, Montgomery HE.

    J Mol Med. 2006 Feb;84(2):126-31. Epub 2006 Jan 17.PMID: 16416313 [PubMed - indexed for MEDLINE]Related articles

    6.

    Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.

    Flavell DM, Ireland H, Stephens JW, Hawe E, Acharya J, Mather H, Hurel SJ, Humphries SE.

    Diabetes. 2005 Feb;54(2):582-6.PMID: 15677519 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.

    Foucher C, Rattier S, Flavell DM, Talmud PJ, Humphries SE, Kastelein JJ, Ayyobi A, Pimstone S, Frohlich J, Ansquer JC, Steiner G; DAIS investigators.

    Pharmacogenetics. 2004 Dec;14(12):823-9.PMID: 15608561 [PubMed - indexed for MEDLINE]Related articles

    8.

    Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

    Putt W, Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, Humphries SE, Talmud PJ; EARSII group.

    Hum Mol Genet. 2004 Aug 1;13(15):1587-97. Epub 2004 Jun 2.PMID: 15175273 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Visceral obesity without insulin resistance in late-onset obesity rats.

    Bains RK, Wells SE, Flavell DM, Fairhall KM, Strom M, Le Tissier P, Robinson IC.

    Endocrinology. 2004 Jun;145(6):2666-79. Epub 2004 Mar 19.PMID: 15033913 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones.

    Wells SE, Flavell DM, Bisset GW, Houston PA, Christian H, Fairhall KM, Robinson IC.

    J Physiol. 2003 Aug 15;551(Pt 1):323-36. Epub 2003 Jun 17.PMID: 12813157 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies.

    Elrayess MA, Webb KE, Flavell DM, Syvänne M, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Jukema JW, Kastelein JJ, Zwinderman AH, Humphries SE.

    Atherosclerosis. 2003 May;168(1):131-8.PMID: 12732396 [PubMed - indexed for MEDLINE]Related articles

    12.

    Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men.

    Waterworth DM, Talmud PJ, Luan J, Flavell DM, Byrne CD, Humphries SE, Wareham NJ.

    Biochim Biophys Acta. 2003 Apr 17;1637(3):200-6.PMID: 12697301 [PubMed - indexed for MEDLINE]Related articles

    13.

    Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.

    Talmud PJ, Martin S, Steiner G, Flavell DM, Whitehouse DB, Nagl S, Jackson R, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Humphries SE, Syvänne M; Diabetes Atherosclerosis Intervention Study Investigators.

    Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):644-9. Epub 2003 Mar 6.PMID: 12692006 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.

    Eurlings PM, van der Kallen CJ, Geurts JM, Flavell DM, de Bruin TW.

    Mol Genet Metab. 2002 Dec;77(4):274-81.PMID: 12468272 [PubMed - indexed for MEDLINE]Related articles

    15.

    Haplotype analysis of the PPARgamma Pro12Ala and C1431T variants reveals opposing associations with body weight.

    Doney A, Fischer B, Frew D, Cumming A, Flavell DM, World M, Montgomery HE, Boyle D, Morris A, Palmer CN.

    BMC Genet. 2002 Nov 13;3:21. Epub 2002 Nov 13.PMID: 12429071 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

    Jamshidi Y, Flavell DM, Hawe E, MacCallum PK, Meade TW, Humphries SE.

    Atherosclerosis. 2002 Jul;163(1):183-92.PMID: 12048138 [PubMed - indexed for MEDLINE]Related articles

    17.

    Characterization of the human PPARalpha promoter: identification of a functional nuclear receptor response element.

    Pineda Torra I, Jamshidi Y, Flavell DM, Fruchart JC, Staels B.

    Mol Endocrinol. 2002 May;16(5):1013-28.PMID: 11981036 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.

    Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvänne M.

    Circulation. 2002 Mar 26;105(12):1440-5.PMID: 11914252 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension.

    Jamshidi Y, Montgomery HE, Hense HW, Myerson SG, Torra IP, Staels B, World MJ, Doering A, Erdmann J, Hengstenberg C, Humphries SE, Schunkert H, Flavell DM.

    Circulation. 2002 Feb 26;105(8):950-5.PMID: 11864924 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects.

    Flavell DM, Pineda Torra I, Jamshidi Y, Evans D, Diamond JR, Elkeles RS, Bujac SR, Miller G, Talmud PJ, Staels B, Humphries SE.

    Diabetologia. 2000 May;43(5):673-80.PMID: 10855543 [PubMed - indexed for MEDLINE]Related articles

    21.

    Effects of growth hormone secretagogues in the transgenic growth-retarded (Tgr) rat.

    Wells T, Flavell DM, Wells SE, Carmignac DF, Robinson IC.

    Endocrinology. 1997 Feb;138(2):580-7.PMID: 9002989 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Pituitary growth hormone-releasing factor receptor expression in normal and dwarf rats.

    Carmignac DF, Flavell DM, Robinson IC.

    Neuroendocrinology. 1996 Sep;64(3):177-85.PMID: 8875435 [PubMed - indexed for MEDLINE]Related articles

    23.

    Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH-releasing factor neurons.

    Flavell DM, Wells T, Wells SE, Carmignac DF, Thomas GB, Robinson IC.

    EMBO J. 1996 Aug 1;15(15):3871-9.PMID: 8670892 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat.

    Gabrielsson BG, Carmignac DF, Flavell DM, Robinson IC.

    Endocrinology. 1995 Jan;136(1):209-17.PMID: 7828533 [PubMed - indexed for MEDLINE]Related articles

    25.

    Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene.

    Ackrill AM, Foster GR, Laxton CD, Flavell DM, Stark GR, Kerr IM.

    Nucleic Acids Res. 1991 Aug 25;19(16):4387-93.PMID: 1832217 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    5 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity